Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$643M |
| 2 |
AT&T
T
|
+$311M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$306M |
| 4 |
Microsoft
MSFT
|
+$292M |
| 5 |
Ametek
AME
|
+$215M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$887M |
| 2 |
Apple
AAPL
|
+$694M |
| 3 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$616M |
| 4 |
Amazon
AMZN
|
+$596M |
| 5 |
Linde
LIN
|
+$531M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.39% |
| 2 | Financials | 6.67% |
| 3 | Healthcare | 6.18% |
| 4 | Industrials | 4.97% |
| 5 | Consumer Discretionary | 4.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DHBCU
2376
DELISTED
DHB Capital Corp. Unit
DHBCU
| $7.46M | ﹤0.01% |
755,308
-176,598
| -19% | -$1.75M |
|
2377
Clarivate
CLVT
$1.27B
| $7.45M | ﹤0.01% |
340,358
-976,776
| -74% | -$23.8M |
|
|
ACCD
2378
DELISTED
Accolade Inc
ACCD
| $7.44M | ﹤0.01% |
176,448
+6,890
| +4% | +$324K |
|
2379
PUT
Intercontinental Exchange
ICE
$85.6B
| $7.44M | ﹤0.01% |
64,800
-120,000
| -65% | -$14.2M |
|
2380
Trupanion
TRUP
$1.07B
| $7.43M | ﹤0.01% |
95,639
+52,309
| +121% | +$5.16M |
|
|
DCRN
2381
DELISTED
Decarbonization Plus Acquisition Corporation II Class A Common stock
DCRN
| $7.42M | ﹤0.01% |
752,054
+1,325
| +0.2% | +$13.1K |
|
2382
PUT
Cognizant
CTSH
$24.9B
| $7.42M | ﹤0.01% |
+100,000
| New | +$7.38M |
|
|
ETRN
2383
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
| $7.42M | ﹤0.01% |
731,678
-162,344
| -18% | -$1.43M |
|
|
SOHU
2384
Sohu.com
SOHU
$362M
| $7.38M | ﹤0.01% |
354,263
+329,529
| +1,332% | +$7.04M |
|
|
MDP
2385
DELISTED
Meredith Corporation
MDP
| $7.38M | ﹤0.01% |
132,446
+74,627
| +129% | +$3.26M |
|
|
SVC
2386
Service Properties Trust
SVC
$1.04B
| $7.38M | ﹤0.01% |
131,598
+125,859
| +2,193% | +$7.16M |
|
|
NOAC
2387
DELISTED
Natural Order Acquisition Corp. Common Stock
NOAC
| $7.36M | ﹤0.01% |
750,374
| – | – |
|
2388
PUT
Host Hotels & Resorts
HST
$17.2B
| $7.35M | ﹤0.01% |
+450,100
| New | +$7.3M |
|
|
CODX
2389
Co-Diagnostics
CODX
$5.31M
| $7.34M | ﹤0.01% |
25,150
+10,235
| +69% | +$2.99M |
|
2390
Clean Energy Fuels
CLNE
$427M
| $7.34M | ﹤0.01% |
900,659
+684,780
| +317% | +$5.45M |
|
2391
Petrobras Class A
PBR.A
$111B
| $7.33M | ﹤0.01% |
733,427
+431,349
| +143% | +$4.46M |
|
|
KYNB
2392
Kyntra Bio
KYNB
$27.2M
| $7.33M | ﹤0.01% |
28,692
+28,233
| +6,151% | +$10M |
|
2393
CXApp
CXAI
$13.4M
| $7.32M | ﹤0.01% |
736,855
| – | – |
|
|
ERF
2394
DELISTED
Enerplus Corporation
ERF
| $7.32M | ﹤0.01% |
914,930
+643,976
| +238% | +$4.01M |
|
2395
Check Point Software Technologies
CHKP
$13B
| $7.3M | ﹤0.01% |
64,601
-375,705
| -85% | -$45.8M |
|
|
CPAR
2396
DELISTED
Catalyst Partners Acquisition Corp. Class A Ordinary Share
CPAR
| $7.3M | ﹤0.01% |
+750,000
| New | +$7.28M |
|
|
DENN
2397
DELISTED
Denny's
DENN
| $7.29M | ﹤0.01% |
445,836
+80,384
| +22% | +$1.26M |
|
|
DRNA
2398
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $7.28M | ﹤0.01% |
361,222
+25,736
| +8% | +$711K |
|
2399
Impinj
PI
$4.62B
| $7.28M | ﹤0.01% |
127,363
-85,882
| -40% | -$4.39M |
|
2400
On Holding
ONON
$12.1B
| $7.27M | ﹤0.01% |
+241,374
| New | +$8.48M |
|
Similar funds
Millennium Management's Q3 2021 Portfolio in Review
As of Q3 2021, Millennium Management held 7,698 positions worth $167B, up 2.3% from $163B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Millennium Management deployed $8.65B of net new capital in Q3 2021, opening 1,244 new positions and adding to 2,720 existing holdings. Its largest new stake was Sight Sciences: 1,577,092 shares worth $35.8M.
By sector, the portfolio is most concentrated in Technology at 7.4% of assets, down from 7.8% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $694M trimmed.
- Millennium Management's largest Q3 2021 buy was Sight Sciences: 1,577,092 shares worth $35.8M.
- Millennium Management added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $643M increase.
- Millennium Management's biggest Q3 2021 reduction was Apple, cutting an estimated $694M.
- Millennium Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $887M.
- Millennium Management's ten largest holdings make up 18% of its $167B portfolio in Q3 2021.
- Millennium Management opened 1,244 new positions and closed 981 in Q3 2021.
- Millennium Management's portfolio value rose 2.3% quarter-over-quarter to $167B.
Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.